# Automatic phenotyping using exhaustive projection pursuit

**Authors:** Wayne A. Moore, Stephen W. Meehan, Connor Meehan, David R. Parks, Guenther Walther, Leonore A. Herzenberg

PMC · DOI: 10.1038/s42003-025-08581-z · 2025-08-12

## TL;DR

A new automated tool called EPP identifies cell populations in flow cytometry data by analyzing two-dimensional projections and optimizing gating regions.

## Contribution

EPP introduces an automated, statistically significant method for phenotyping in flow cytometry data using exhaustive projection pursuit.

## Key findings

- EPP identifies phenotypes through optimized two-dimensional projections and statistically significant gating regions.
- The tool was validated on four well-characterized flow cytometry datasets.
- EPP's C++ code is freely available and integrates with software like MATLAB and FlowJo.

## Abstract

One of the most common objectives in the analysis of flow cytometry data is the identification and delineation of phenotypes, distinct populations of cells with shared characteristics in the measurement dimensions. We have developed an automated tool to comprehensively identify these cell populations by Exhaustive Projection Pursuit (EPP). The method evaluates all two-dimensional projections among the suitable data dimensions and creates an optimized sequence of statistically significant gating regions that identify all phenotypes supported by the data. We evaluate the results of EPP on four well characterized data sets from the literature. The C++ code for EPP can be called from any computing environment. We illustrate this with a MATLAB utility that integrates EPP with FlowJo. All source code is freely available.

An automated tool (EPP) identifies distinct cell phenotypes in flow cytometry data through optimized 2D gating as shown in 4 published datasets. EPP’ C++ code integrates with any software, as demonstrated in MATLAB with FlowJo.

## Full-text entities

- **Genes:** FECH (ferrochelatase) [NCBI Gene 2235] {aka EPP, EPP1, FCE}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, CD34 (CD34 molecule) [NCBI Gene 947], FUT4 (fucosyltransferase 4) [NCBI Gene 2526] {aka CD15, ELFT, FCT3A, FUC-TIV, FUTIV, LeX}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 5788] {aka B220, CD45, CD45R, GP180, IMD105, L-CA}, CCR7 (C-C motif chemokine receptor 7) [NCBI Gene 1236] {aka BLR2, CC-CKR-7, CCR-7, CD197, CDw197, CMKBR7}, NCAM1 (neural cell adhesion molecule 1) [NCBI Gene 4684] {aka CD56, MSK39, NCAM}, CD1C (CD1c molecule) [NCBI Gene 911] {aka BDCA1, CD1, R7}, CD19 (CD19 molecule) [NCBI Gene 930] {aka B4, CVID3}, CD38 (CD38 molecule) [NCBI Gene 952] {aka ADPRC 1, ADPRC1, cADPR1}, CD27 (CD27 molecule) [NCBI Gene 939] {aka S152, S152. LPFS2, T14, TNFRSF7, Tp55}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, FCGR3A (Fc gamma receptor IIIa) [NCBI Gene 2214] {aka CD16-II, CD16A, FCG3, FCGR3, FCRIIIA, FcGRIIIA}, IGHG3 (immunoglobulin heavy constant gamma 3 (G3m marker)) [NCBI Gene 3502] {aka IgG3}, LOC102723407 (immunoglobulin heavy variable 4-38-2-like) [NCBI Gene 102723407] {aka IGHV4, IGHV4-30, IGHV4-38-2, IGHV4-39, IGHV4-b, IGVH4-39}, MME (membrane metalloendopeptidase) [NCBI Gene 4311] {aka CALLA, CD10, CMT2T, NEP, SCA43, SFE}, IL3RA (interleukin 3 receptor subunit alpha) [NCBI Gene 3563] {aka CD123, IL-3R-alpha, IL3R, IL3RAY, IL3RX, IL3RY}, ITGAX (integrin subunit alpha X) [NCBI Gene 3687] {aka CD11C, SLEB6}, THBD (thrombomodulin) [NCBI Gene 7056] {aka AHUS6, BDCA-3, BDCA3, CD141, THPH12, THRM}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}
- **Diseases:** DBM (MESH:D015451), BLUE (OMIM:190900)
- **Chemicals:** FMO (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** OMIP- — Rattus norvegicus (Rat), Undefined cell line type (CVCL_KS85), ORANGE — Pseudetroplus maculatus (Orange chromide), Spontaneously immortalized cell line (CVCL_C5YW)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12343891/full.md

---
Source: https://tomesphere.com/paper/PMC12343891